FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Bolton Thoracic Stent Recall is Class 1: FDA

FDA says a Bolton Medical recall of its RelayPro thoracic stent graft system is Class 1.

latest-news-card-1
Human Drugs

Clinical Electronic Structured Protocol Template

FDA publishes for reference only an International Council for Harmonization template on a clinical electronic structured harmonized protocol.

latest-news-card-1
Human Drugs

Comments on Increasing Access to Non-Prescription Drugs

Four stakeholders comment to FDA on ways to increase patient access to nonprescription drugs.

latest-news-card-1
Biologics

FDA to Convene Panel on Modernas mRNA Flu Vaccine

FDA announces a 6/18 advisory committee meeting to review Modernas controversial mRNA-based seasonal influenza vaccine.

Biologics

RFK Jr. Ignores Hill Request on Anti-Vax Activist HHS Role

HHS secretary Robert F. Kennedy Jr. faces renewed scrutiny from Senate Democrats for ignoring requests about the role of longtime anti-vaccine activis...

latest-news-card-1
Human Drugs

Lilly Says Retatrutide Delivered Up to 30% Weight Loss

Eli Lilly reports that its investigational obesity drug retatrutide produced weight-loss results approaching those historically associated with bariat...

latest-news-card-1
Human Drugs

All India Institute Clinical Trial Issues

FDA warns Dr. Sourav Mishra about violations in his conduct of a clinical investigation at the All India Institute of Medical Sciences in Bhubaneswar,...

latest-news-card-1
Human Drugs

Naseem Jaffrani BIMO Violation

FDA warns Alexandria, LA-based cardiologist Naseem Jaffrani about his failure to conduct a clinical investigation according to the investigational pla...

latest-news-card-1
FDA General

Will the Next Commissioner Learn from Makarys Mistakes?

Former FDA associate commissioner Peter Pitts says FDA has an opportunity with the resignation of commissioner Marty Makary to reset its operation and...

latest-news-card-1
Biologics

FDA Has to Build CRISPR Edit Review Protocol

A Clinical Trial Vanguard post describes the issues facing FDA in determining how to review and approve a BLA for a one-time CRISPR gene edit to addre...